Y10S 930/28
Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide
Official title: Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin
Y10S930/28 (Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide) appears on 171 US grants and 21 published applications in this corpus.
Search patents in Y10S- Granted patents
- 171
- Published applications
- 21
- Assignees
- 68
- Inventors
- 197
- Latest grant
- 12 Aug 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 12 | 0 |
| 1977 | 14 | 0 |
| 1978 | 31 | 0 |
| 1979 | 8 | 0 |
| 1980 | 11 | 0 |
| 1981 | 13 | 0 |
| 1982 | 5 | 0 |
| 1983 | 3 | 0 |
| 1984 | 7 | 0 |
| 1985 | 6 | 0 |
| 1986 | 4 | 0 |
| 1987 | 7 | 0 |
| 1988 | 10 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 2 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 2 | 0 |
| 1999 | 4 | 0 |
| 2000 | 2 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 1 | 2 |
| 2004 | 1 | 4 |
| 2005 | 1 | 1 |
| 2006 | 0 | 2 |
| 2007 | 4 | 5 |
| 2008 | 9 | 5 |
| 2009 | 2 | 0 |
| 2010 | 4 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Transition metal chelating beads12 Aug 2025US 12,385,907 B2Roche Diagnostics Operations, Inc.
- Truncated 24kDa basic fibroblast growth factor28 Sep 2010US 7,803,772 B2The Scripps Research Institute
- Sushi peptide multimer27 Jul 2010US 7,763,704 B2National University of Singapore
- Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof22 Jun 2010US 7,741,289 B2Schering Corporation
- Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof8 Jun 2010US 7,732,413 B2Schering Corporation
- Transition metal chelating beads13 Jan 2022US 2022/0009963 A1Roche Diagnostics Operations, Inc.
- Truncated 24kda basic fibroblast growth factor10 Jun 2010US 2010/0144632 A1The Scripps Research Institute
- Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof25 Sep 2008US 2008/0234248 A1Schering Corporation
- Substituted Azetidinone Compounds, Processes for Preparing the Same, Formulations and Uses Thereof28 Aug 2008US 2008/0207585 A1Schering Corporation
- Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof21 Aug 2008US 2008/0200446 A1Schering Corporation
Most cited
By later US patents
- Continuous release pharmaceutical compositions336US 4,767,628 AImperial Chemical Industries PLC · 1988
- PGlu-D-Met-Trp-Ser-Tyr-D-Ala-Leu-Arg-Pro-Gly-NH.sub.2 and intermediates122US 3,941,763 AAmerican Home Products Corporation · 1976
- Synthesis of protein with an identification peptide114US 4,703,004 AImmunex Corporation · 1987
- Method of diagnosing blood clots using fibrin-binding proteins110US 5,217,705 ANeoRx Corporation · 1993
- Continuous release pharmaceutical compositions formed by freeze drying acetic acid solutions of polylactide88US 5,004,602 AImperial Chemical Industries PLC · 1991